2016-08-03
AUTHORSThomas Zeller , Ulrich Beschorner , Elias Noory
ABSTRACTThree major clinical symptoms result from significant renal artery stenosis (RAS): arterial hypertension, nephropathy, and destabilizing cardiac syndromes. Main etiologies of RAS are atherosclerosis (approximately 90 %) and fibromuscular dysplasia (FMD). Atherosclerotic RAS has a considerable overlap with atherosclerotic manifestation elsewhere and is associated with an overall poor prognosis. Technical improvements of diagnostic and interventional endovascular tools have led to a more widespread use of transluminal renal artery revascularization and extension of interventional indications during the past three decades. Plain balloon angioplasty is still considered the method of choice for the treatment of FMD, whereas stent implantation is indicated in ostial atherosclerotic RAS. However, despite positive retrospective single center experiences, none of the published randomized controlled trials could prove a benefit of RAS revascularization compared to medical management. These negative trials including the CORAL trial had significant flaws in study design; crucial for a clinical benefit of revascularization of RAS is a proper patient selection, revascularization is only indicated in hemodynamic relevant RAS. This chapter summarizes the epidemiology, indications for treatment, and technical aspects of endovascular treatment of RAS. More... »
PAGES3-27
Interventional Therapies for Secondary and Essential Hypertension
ISBN
978-3-319-34140-8
978-3-319-34141-5
http://scigraph.springernature.com/pub.10.1007/978-3-319-34141-5_1
DOIhttp://dx.doi.org/10.1007/978-3-319-34141-5_1
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1023568817
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Abteilung Kardiologie und Angiologie II, Universit\u00e4ts-Herzzentrum Freiburg \u2013 Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany",
"id": "http://www.grid.ac/institutes/grid.418466.9",
"name": [
"Abteilung Kardiologie und Angiologie II, Universit\u00e4ts-Herzzentrum Freiburg \u2013 Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany"
],
"type": "Organization"
},
"familyName": "Zeller",
"givenName": "Thomas",
"id": "sg:person.01306206724.74",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Abteilung Kardiologie und Angiologie II, Universit\u00e4ts-Herzzentrum Freiburg \u2013 Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany",
"id": "http://www.grid.ac/institutes/grid.418466.9",
"name": [
"Abteilung Kardiologie und Angiologie II, Universit\u00e4ts-Herzzentrum Freiburg \u2013 Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany"
],
"type": "Organization"
},
"familyName": "Beschorner",
"givenName": "Ulrich",
"id": "sg:person.0642326255.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642326255.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Abteilung Kardiologie und Angiologie II, Universit\u00e4ts-Herzzentrum Freiburg \u2013 Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany",
"id": "http://www.grid.ac/institutes/grid.418466.9",
"name": [
"Abteilung Kardiologie und Angiologie II, Universit\u00e4ts-Herzzentrum Freiburg \u2013 Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany"
],
"type": "Organization"
},
"familyName": "Noory",
"givenName": "Elias",
"id": "sg:person.0610302262.30",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610302262.30"
],
"type": "Person"
}
],
"datePublished": "2016-08-03",
"datePublishedReg": "2016-08-03",
"description": "Three major clinical symptoms result from significant renal artery stenosis (RAS): arterial hypertension, nephropathy, and destabilizing cardiac syndromes. Main etiologies of RAS are atherosclerosis (approximately 90\u2009%) and fibromuscular dysplasia (FMD). Atherosclerotic RAS has a considerable overlap with atherosclerotic manifestation elsewhere and is associated with an overall poor prognosis. Technical improvements of diagnostic and interventional endovascular tools have led to a more widespread use of transluminal renal artery revascularization and extension of interventional indications during the past three decades. Plain balloon angioplasty is still considered the method of choice for the treatment of FMD, whereas stent implantation is indicated in ostial atherosclerotic RAS. However, despite positive retrospective single center experiences, none of the published randomized controlled trials could prove a benefit of RAS revascularization compared to medical management. These negative trials including the CORAL trial had significant flaws in study design; crucial for a clinical benefit of revascularization of RAS is a proper patient selection, revascularization is only indicated in hemodynamic relevant RAS. This chapter summarizes the epidemiology, indications for treatment, and technical aspects of endovascular treatment of RAS.",
"editor": [
{
"familyName": "Tsioufis",
"givenName": "Costas",
"type": "Person"
},
{
"familyName": "Schmieder",
"givenName": "Roland E.",
"type": "Person"
},
{
"familyName": "Mancia",
"givenName": "Giuseppe",
"type": "Person"
}
],
"genre": "chapter",
"id": "sg:pub.10.1007/978-3-319-34141-5_1",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": {
"isbn": [
"978-3-319-34140-8",
"978-3-319-34141-5"
],
"name": "Interventional Therapies for Secondary and Essential Hypertension",
"type": "Book"
},
"keywords": [
"renal artery stenosis",
"atherosclerotic renal artery stenosis",
"fibromuscular dysplasia",
"ostial atherosclerotic renal artery stenosis",
"treatment of FMD",
"retrospective single-center experience",
"significant renal artery stenosis",
"interventional endovascular tools",
"renal artery revascularization",
"single-center experience",
"overall poor prognosis",
"plain balloon angioplasty",
"major clinical symptoms",
"proper patient selection",
"relevant renal artery stenosis",
"CORAL trial",
"artery revascularization",
"arterial hypertension",
"atherosclerotic manifestations",
"renovascular hypertension",
"center experience",
"main etiology",
"endovascular treatment",
"clinical symptoms",
"artery stenosis",
"medical management",
"patient selection",
"poor prognosis",
"balloon angioplasty",
"clinical benefit",
"stent implantation",
"cardiac syndrome",
"interventional indications",
"revascularization",
"RAS revascularization",
"negative trials",
"endovascular tools",
"study design",
"trials",
"hypertension",
"treatment",
"method of choice",
"considerable overlap",
"indications",
"nephropathy",
"angioplasty",
"widespread use",
"stenosis",
"atherosclerosis",
"prognosis",
"dysplasia",
"syndrome",
"etiology",
"symptoms",
"technical improvements",
"epidemiology",
"technical aspects",
"manifestations",
"intervention",
"implantation",
"benefits",
"management",
"improvement",
"experience",
"significant flaws",
"use",
"overlap",
"decades",
"choice",
"aspects",
"tool",
"selection",
"method",
"chapter",
"extension",
"design",
"flaws"
],
"name": "Interventions for Renovascular Hypertension",
"pagination": "3-27",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1023568817"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/978-3-319-34141-5_1"
]
}
],
"publisher": {
"name": "Springer Nature",
"type": "Organisation"
},
"sameAs": [
"https://doi.org/10.1007/978-3-319-34141-5_1",
"https://app.dimensions.ai/details/publication/pub.1023568817"
],
"sdDataset": "chapters",
"sdDatePublished": "2022-05-10T10:39",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/chapter/chapter_161.jsonl",
"type": "Chapter",
"url": "https://doi.org/10.1007/978-3-319-34141-5_1"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-34141-5_1'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-34141-5_1'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-34141-5_1'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-34141-5_1'
This table displays all metadata directly associated to this object as RDF triples.
161 TRIPLES
23 PREDICATES
101 URIs
94 LITERALS
7 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/978-3-319-34141-5_1 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1102 |
3 | ″ | schema:author | Naf58eb858704474592ed71ab8d14c19d |
4 | ″ | schema:datePublished | 2016-08-03 |
5 | ″ | schema:datePublishedReg | 2016-08-03 |
6 | ″ | schema:description | Three major clinical symptoms result from significant renal artery stenosis (RAS): arterial hypertension, nephropathy, and destabilizing cardiac syndromes. Main etiologies of RAS are atherosclerosis (approximately 90 %) and fibromuscular dysplasia (FMD). Atherosclerotic RAS has a considerable overlap with atherosclerotic manifestation elsewhere and is associated with an overall poor prognosis. Technical improvements of diagnostic and interventional endovascular tools have led to a more widespread use of transluminal renal artery revascularization and extension of interventional indications during the past three decades. Plain balloon angioplasty is still considered the method of choice for the treatment of FMD, whereas stent implantation is indicated in ostial atherosclerotic RAS. However, despite positive retrospective single center experiences, none of the published randomized controlled trials could prove a benefit of RAS revascularization compared to medical management. These negative trials including the CORAL trial had significant flaws in study design; crucial for a clinical benefit of revascularization of RAS is a proper patient selection, revascularization is only indicated in hemodynamic relevant RAS. This chapter summarizes the epidemiology, indications for treatment, and technical aspects of endovascular treatment of RAS. |
7 | ″ | schema:editor | N53b0a979e5804c04bef34d49f43d5b5e |
8 | ″ | schema:genre | chapter |
9 | ″ | schema:inLanguage | en |
10 | ″ | schema:isAccessibleForFree | false |
11 | ″ | schema:isPartOf | Ne53653dd0cea4273bde3828b2766bf08 |
12 | ″ | schema:keywords | CORAL trial |
13 | ″ | ″ | RAS revascularization |
14 | ″ | ″ | angioplasty |
15 | ″ | ″ | arterial hypertension |
16 | ″ | ″ | artery revascularization |
17 | ″ | ″ | artery stenosis |
18 | ″ | ″ | aspects |
19 | ″ | ″ | atherosclerosis |
20 | ″ | ″ | atherosclerotic manifestations |
21 | ″ | ″ | atherosclerotic renal artery stenosis |
22 | ″ | ″ | balloon angioplasty |
23 | ″ | ″ | benefits |
24 | ″ | ″ | cardiac syndrome |
25 | ″ | ″ | center experience |
26 | ″ | ″ | chapter |
27 | ″ | ″ | choice |
28 | ″ | ″ | clinical benefit |
29 | ″ | ″ | clinical symptoms |
30 | ″ | ″ | considerable overlap |
31 | ″ | ″ | decades |
32 | ″ | ″ | design |
33 | ″ | ″ | dysplasia |
34 | ″ | ″ | endovascular tools |
35 | ″ | ″ | endovascular treatment |
36 | ″ | ″ | epidemiology |
37 | ″ | ″ | etiology |
38 | ″ | ″ | experience |
39 | ″ | ″ | extension |
40 | ″ | ″ | fibromuscular dysplasia |
41 | ″ | ″ | flaws |
42 | ″ | ″ | hypertension |
43 | ″ | ″ | implantation |
44 | ″ | ″ | improvement |
45 | ″ | ″ | indications |
46 | ″ | ″ | intervention |
47 | ″ | ″ | interventional endovascular tools |
48 | ″ | ″ | interventional indications |
49 | ″ | ″ | main etiology |
50 | ″ | ″ | major clinical symptoms |
51 | ″ | ″ | management |
52 | ″ | ″ | manifestations |
53 | ″ | ″ | medical management |
54 | ″ | ″ | method |
55 | ″ | ″ | method of choice |
56 | ″ | ″ | negative trials |
57 | ″ | ″ | nephropathy |
58 | ″ | ″ | ostial atherosclerotic renal artery stenosis |
59 | ″ | ″ | overall poor prognosis |
60 | ″ | ″ | overlap |
61 | ″ | ″ | patient selection |
62 | ″ | ″ | plain balloon angioplasty |
63 | ″ | ″ | poor prognosis |
64 | ″ | ″ | prognosis |
65 | ″ | ″ | proper patient selection |
66 | ″ | ″ | relevant renal artery stenosis |
67 | ″ | ″ | renal artery revascularization |
68 | ″ | ″ | renal artery stenosis |
69 | ″ | ″ | renovascular hypertension |
70 | ″ | ″ | retrospective single-center experience |
71 | ″ | ″ | revascularization |
72 | ″ | ″ | selection |
73 | ″ | ″ | significant flaws |
74 | ″ | ″ | significant renal artery stenosis |
75 | ″ | ″ | single-center experience |
76 | ″ | ″ | stenosis |
77 | ″ | ″ | stent implantation |
78 | ″ | ″ | study design |
79 | ″ | ″ | symptoms |
80 | ″ | ″ | syndrome |
81 | ″ | ″ | technical aspects |
82 | ″ | ″ | technical improvements |
83 | ″ | ″ | tool |
84 | ″ | ″ | treatment |
85 | ″ | ″ | treatment of FMD |
86 | ″ | ″ | trials |
87 | ″ | ″ | use |
88 | ″ | ″ | widespread use |
89 | ″ | schema:name | Interventions for Renovascular Hypertension |
90 | ″ | schema:pagination | 3-27 |
91 | ″ | schema:productId | N08965a4486ce4037837fd9b65002e2ff |
92 | ″ | ″ | N651237779d6e4b5995a3228e47c1deb8 |
93 | ″ | schema:publisher | N8c4dddf4466b4a7b8f5cc151b9945e32 |
94 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1023568817 |
95 | ″ | ″ | https://doi.org/10.1007/978-3-319-34141-5_1 |
96 | ″ | schema:sdDatePublished | 2022-05-10T10:39 |
97 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
98 | ″ | schema:sdPublisher | N8ed47297c265469793de7885789e07ea |
99 | ″ | schema:url | https://doi.org/10.1007/978-3-319-34141-5_1 |
100 | ″ | sgo:license | sg:explorer/license/ |
101 | ″ | sgo:sdDataset | chapters |
102 | ″ | rdf:type | schema:Chapter |
103 | N08965a4486ce4037837fd9b65002e2ff | schema:name | dimensions_id |
104 | ″ | schema:value | pub.1023568817 |
105 | ″ | rdf:type | schema:PropertyValue |
106 | N40d088abdf444b53ad08a42840a0900b | schema:familyName | Tsioufis |
107 | ″ | schema:givenName | Costas |
108 | ″ | rdf:type | schema:Person |
109 | N53b0a979e5804c04bef34d49f43d5b5e | rdf:first | N40d088abdf444b53ad08a42840a0900b |
110 | ″ | rdf:rest | Na858e526bb474a1eae65aa7c7c92026d |
111 | N651237779d6e4b5995a3228e47c1deb8 | schema:name | doi |
112 | ″ | schema:value | 10.1007/978-3-319-34141-5_1 |
113 | ″ | rdf:type | schema:PropertyValue |
114 | N81dd3fb3fc7042898a5b2ef77a31d11a | rdf:first | sg:person.0642326255.24 |
115 | ″ | rdf:rest | Nc5120a374c824747814a47da22ef5c4f |
116 | N8c4dddf4466b4a7b8f5cc151b9945e32 | schema:name | Springer Nature |
117 | ″ | rdf:type | schema:Organisation |
118 | N8ed47297c265469793de7885789e07ea | schema:name | Springer Nature - SN SciGraph project |
119 | ″ | rdf:type | schema:Organization |
120 | Na858e526bb474a1eae65aa7c7c92026d | rdf:first | Ndd2739307f094ff3947273b814870024 |
121 | ″ | rdf:rest | Nc10e53654e9940d18e547ec3081385a2 |
122 | Naf58eb858704474592ed71ab8d14c19d | rdf:first | sg:person.01306206724.74 |
123 | ″ | rdf:rest | N81dd3fb3fc7042898a5b2ef77a31d11a |
124 | Nc10e53654e9940d18e547ec3081385a2 | rdf:first | Nd290edfc517c498584a9050d3dccc367 |
125 | ″ | rdf:rest | rdf:nil |
126 | Nc5120a374c824747814a47da22ef5c4f | rdf:first | sg:person.0610302262.30 |
127 | ″ | rdf:rest | rdf:nil |
128 | Nd290edfc517c498584a9050d3dccc367 | schema:familyName | Mancia |
129 | ″ | schema:givenName | Giuseppe |
130 | ″ | rdf:type | schema:Person |
131 | Ndd2739307f094ff3947273b814870024 | schema:familyName | Schmieder |
132 | ″ | schema:givenName | Roland E. |
133 | ″ | rdf:type | schema:Person |
134 | Ne53653dd0cea4273bde3828b2766bf08 | schema:isbn | 978-3-319-34140-8 |
135 | ″ | ″ | 978-3-319-34141-5 |
136 | ″ | schema:name | Interventional Therapies for Secondary and Essential Hypertension |
137 | ″ | rdf:type | schema:Book |
138 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
139 | ″ | schema:name | Medical and Health Sciences |
140 | ″ | rdf:type | schema:DefinedTerm |
141 | anzsrc-for:1102 | schema:inDefinedTermSet | anzsrc-for: |
142 | ″ | schema:name | Cardiorespiratory Medicine and Haematology |
143 | ″ | rdf:type | schema:DefinedTerm |
144 | sg:person.01306206724.74 | schema:affiliation | grid-institutes:grid.418466.9 |
145 | ″ | schema:familyName | Zeller |
146 | ″ | schema:givenName | Thomas |
147 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74 |
148 | ″ | rdf:type | schema:Person |
149 | sg:person.0610302262.30 | schema:affiliation | grid-institutes:grid.418466.9 |
150 | ″ | schema:familyName | Noory |
151 | ″ | schema:givenName | Elias |
152 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610302262.30 |
153 | ″ | rdf:type | schema:Person |
154 | sg:person.0642326255.24 | schema:affiliation | grid-institutes:grid.418466.9 |
155 | ″ | schema:familyName | Beschorner |
156 | ″ | schema:givenName | Ulrich |
157 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642326255.24 |
158 | ″ | rdf:type | schema:Person |
159 | grid-institutes:grid.418466.9 | schema:alternateName | Abteilung Kardiologie und Angiologie II, Universitäts-Herzzentrum Freiburg – Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany |
160 | ″ | schema:name | Abteilung Kardiologie und Angiologie II, Universitäts-Herzzentrum Freiburg – Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany |
161 | ″ | rdf:type | schema:Organization |